AbCellera Biologics (ABCL) Prepaid Assets (2020 - 2026)

AbCellera Biologics' Prepaid Assets history runs 7 years deep, the most recent figure standing at $98.1 million for Q1 2026.

• Quarterly Prepaid Assets rose 3.59% year-over-year to $98.1 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $98.1 million (up 3.59% YoY) and the FY2025 annual result came in at $111.1 million, up 65.49% from the prior year.
• Prepaid Assets was $98.1 million for Q1 2026 at AbCellera Biologics, down from $111.1 million in the prior quarter.
• Across five years, Prepaid Assets topped out at $133.0 million in Q3 2025 and bottomed at $28.9 million in Q1 2022.
• A 5-year average of $73.3 million and a median of $67.1 million in 2024 frame the typical range for Prepaid Assets.
• Annual changes were most pronounced in 2022 — Prepaid Assets soared 600.81% — and 2024, when it sank 43.01%.
• AbCellera Biologics' Prepaid Assets stood at $75.4 million in 2022, then declined by 25.99% to $55.8 million in 2023, then increased by 20.3% to $67.1 million in 2024, then soared by 65.49% to $111.1 million in 2025, then fell by 11.71% to $98.1 million in 2026.
• Business Quant data shows ABCL's Prepaid Assets at $98.1 million in Q1 2026, $111.1 million in Q4 2025, and $133.0 million in Q3 2025.